[{"data":1,"prerenderedAt":24},["ShallowReactive",2],{"case-study-insilico-medicine":3},{"data":4},[5],{"slug":6,"company":7,"industry":8,"logo":9,"logoLocal":10,"pdfUrl":11,"quote":12,"quoteAuthor":13,"quoteRole":14,"headline":15,"summary":16,"challenge":17,"solution":18,"results":19},"insilico-medicine","Insilico Medicine","AI Drug Discovery","https:\u002F\u002Fmeet.nanome.ai\u002Fhubfs\u002Finsilico-logo.png","data:image\u002Fpng;base64,iVBORw0KGgoAAAANSUhEUgAAAIAAAACACAMAAAD04JH5AAAAPFBMVEVHcEz\u002F\u002F\u002F5KoET+\u002F\u002F3\u002F\u002F\u002F7\u002F\u002F\u002F7\u002F\u002F\u002F7\u002F\u002F\u002F7\u002F\u002F\u002F7\u002F\u002F\u002F5CnTyPw4uw1a1aqFTp8+i\u002F3b3S58+fy5yAu3xws2vnoFJ5AAAACnRSTlMAj\u002F\u002F\u002FZSOB5V5W\u002FJUXEwAACOxJREFUeJzFW4l24yoM7cPtNGUx2\u002F\u002F\u002F67sSthFeEidxbGZ6eppSc62NKyG+vt4YP\u002F9+u+733887z3hn\u002FGF5Gr+369YP3oerEGD9PjqlXOwvQUDrG8XDXIGA5G90AaDS+Vq40fvT+g5KUJpk8H3m+n\u002Fj+spad4EWJv07G0JBQJb4d\u002Fb6GuunFPyE4CQtsP2x8dk+wQJ7W3zhLEuk9ZMe1sd3nXtPP2nyhRNkcKv21xccQMAyOMcXhP0N6xcEoy90H9YCvX8c7H9cn6Qfqjd+VAbC\u002FkJSYgDBGVH5Ju1PqRUE+qNR+bur9pd1C2CyxAQ7+JAWbt1kfx2rPJus6rfYfdgSbzX+gYdYpzPYiHHOgJMk7aL33Uf3he\u002Fqf11w2WdtLVQRsBmo6HX2SYXug74g7d8GlwIAeGV9Sh44LAFw+IX9FD+4jfxDU\u002FyJPQnDhR5ywNJ9cPTafaxR+WgZ\u002FHVN\u002FNU28g+ueAB\u002F09DDFBP1wZYo4i\u002FLQcc488IBAFYWdnAYPxD2D8N3ehuAdnCJw33hJvd\u002FDas3WwCSDT30749F8CfsL8TUG7jfBoBoTZ9MGCyRGMoBWrjJ+JsD3C\u002FFTQBG0wzhC+9b4l836R\u002Fxn8zsPgCekasW3kVwE\u002FwX62MoBmC3ACielI\u002FiBzcZfy0NvKOJygQ3R+C8YQkknhY6fwQCyX+j4REMh\u002F3oWwTwP6vwC3CjMi8WO3gvKk\u002Fxl\u002Ff\u002FIn8HBNgIsAs0CHh9\u002FIpFU7Qw+sLr\u002FGCKv07wD6g3AkFqEJT3x6ZsgphYLPF1BDL+ehMj\u002FmMkaAAy8A0CWj\u002FR+5MOeCLN9+\u002Ftzo39xWmQBjwvNSHg9x8+hAzq3LcYitz\u002Fg6nqJkWzsv1kB8X+yDRYB9UwTXidK8v4m6wAoCcExRKr\u002FRFHMSJZAACLfYEf8nTe2MRfLQEo8kIgcJCBVh5JSvRK+wj3QJD2kiwDgGQoz1gi2f+Q\u002F0AOLQB8ZqB1h4ijEZIBwEJMiT8y3sngAACSH+yPyjL+hgUANaw2AjAVQLISgGYA4fmoLPhvIP3PAGTIHT6v8LqkfjIEF+ijrKIwwVEC9ul9YeIfzD+XACJYOUJ9Dp1JPXboHhSg67Pnj+NCApYyV\u002F77nVFZ5v9ZbwIIue8iHpkz4MZVAIME2qj8EMEYf2n\u002Fh5zvSIAA9PcAjBKAdgRXfsCRpP4zbXkg4CMJfxoAWAN9wVlz2Lk7i\u002FUhNgKQFu5td6pA0+5EXxQtfL\u002FLEjn\u002FL6uE6APVICjmMgp6JA+qhuDX5CLZkyf4nILPEWHXktPytl1CJkVosr4QvAk7Klky\u002FmZNFAd7uyIEtM2S19M+x4mQ+KJi7fgjFrM0iXghU5cCiFhCfhyV\u002F9r6A1SfaeiCwCP9phHUbGhpILpMwuRhfX5EyVlEBWMVgdx\u002FI2P1vjyI3j8nIvyhH6qSZbhhCACW5gSTUi7EIfBD+L0eRGWxfh\u002F8ZEy0+7MWiGXRkMHWwE7wX5q+K1Kj2fyHdXeEUfV3fKGpf7hcKDBGHPmHc9nTalICJM1uOrcoyxAkn50bGUocn9Rnd6eCIewvWDJrCJGHt8S\u002FWB1hYQOOP5IFq8EGAoudGAqVMHiAKmDrCNUSv2frV\u002FtrOdBAN0nVrM7W0wsAKQGeRLPn1DWR9ERVV\u002FKDyn89279T9Z1Gwgtjn1vcJAH5UZnD8WJO3h37wgpXrvzXS0o1vKazkbZgCLGn4e8DsDwJCqStOTb8YJTawhIl\u002F+D1oXj5zIx8PJMZbdqAeH6xAZoN+c8e41NRxQxB5b+e678wumgbbsW8A4LlzECWaFckkDhashbah8CYoi\u002FPD0PWVrjyz8Q\u002F\u002FFD\u002FBct0oSnFAgHvAjQahS+8QGWeRLNn64PHYlfimUNUZhn8fP3ruvKxHx5EyZeVmubUw8e4VIEpcUA6xqACZCV+pn9IYKywuzEidd1\u002FX79d4K2k5n9TlUcigGDZvjoBrXghEAjL9R3Noh1pbn\u002FOTxX2sX4ACf5+dfxIcf6Bscz+1ZoKytuSVKbFdFXB4gmuTlMDAggVADg07ACgWgA6dtOoBZMCQD0AoAWAXSpQKyrIfQXQj5FTP6+ChRGqpRHilzDC2BihC50Y4982RtgKgY1wSKfHcEhG+CPTgCLaPW7ofNeMUbxbbqiXbqiLGy4CEcXdzUBkxkAUu9kYtunHgUgNgUhPSbs8ii4zmhiq10Jx6ucAeiNVsAzFegjFehGKZwgW1ru2GbUGMCDgx4rNKD3cjG6b27Fb2471tB0TuV6OWBoamAusbMd6sR0LYrhJSHRDSKhnJlZBz0bgkwSaMxESXRHgx74lJE2SdpeShTkluwNgPyWbEeNbeygWbKR\u002FcUZKQyGlemmDowoizRlJaWJSSjEM\u002FwEg3CubCVq8g5Yni3e0gVIQvC\u002F\u002FUFy5oeX6CVreFiZniYnfSEzMkB0LI6fEJLyUmLyQmukRwIKWv5SazYqDJTmlzLJJTq1MTicJ1I\u002Fmyal6IjndTs\u002FNRno+Fih2pOdwT+b6DxpN9hQoZI3oXoVkqGiSKHcXKGZHNEeWaHaX6uQhwRVFqlqm01tlur01IlmmW00I7yA4ulBZy0O7ysW3u6Va\u002FfFSbXtYvSxWu48Xq4d20bLYslyvXi7XP3Fg8OqBRdg6sHj66GzzyEadc2TzzKGV3nFo9crx6d\u002F6sZ1\u002FdGznDzq2Wx5clmEeH1yOM99ubJJHB\u002FLo1iyObsXR8ZRgNg01Lx4eLw+v9Z7Daz0\u002FvH79AH\u002Ft+D7dOb4PBx\u002FfbzQwpPMaGLZbODZ7SA5u4ahNLGpqYlHPNbG83cgz+cLuNp701DHdDgQiKvcXNDLNWrkvaOVqLfGKZramnf5RO1\u002F6RDtfyw+4obEUBk9raHyqpVOX\u002FO8jTaXFEi9pal1UMB619X6gsXhsrJ83NqeTGptra7debe12Q2v38fZXx7eMyjM\u002FPKO5XV6vmrf361Pa+6+\u002F4NDkTJdc8bj+ksv113zkRSe\u002FvOh02lWrjateJ113aywxrdX\u002Fz0KgL7ruJy+c2in+nnvps\u002FrCNVc+20uvr9QfDkFw6bXf6y8+X3\u002F1+\u002FrL78dc\u002F\u002F8f0dokVoSZMbgAAAAASUVORK5CYII=","\u002Fdownloads\u002Fcase-study-insilico.pdf","VR enables medicinal chemists to look at molecules closely before placing a billion-dollar, life-or-death wager, while unleashing creativity and encouraging collaboration across both disciplinary and physical borders.","Alex Zhavoronkov, PhD","CEO of Insilico Medicine","Scientists use Virtual Reality to refine new AI-generated drugs for COVID-19","Nanome and Insilico Medicine co-authored research describing 10 potential small molecule inhibitors targeting the SARS-CoV-2 main protease, generated by AI and refined in VR.","The daunting number of chemical structures that can be generated from scratch means conventional computational drug design approaches are limited in scope.","Insilico's AI platform generates novel drug-like molecules, which are then analyzed and refined by medicinal chemists using Nanome's VR environment for intuitive 3D visualization.",[20,21,22,23],"10 potential non-covalent inhibitors targeting SARS-CoV-2 main protease","Novel molecular structures not found in existing databases","AI-generated compounds collaboratively optimized in VR","Pioneered the combination of generative AI and immersive VR for drug design",1775871861213]